ESCRS - PO094 - Corneal And Scleral Melt Following The Chronic Use Of Hydroquinone-Containing Skin-Lightening Cream

Corneal And Scleral Melt Following The Chronic Use Of Hydroquinone-Containing Skin-Lightening Cream

Published 2025 - 43rd Congress of the ESCRS

Reference: PO094 | Type: Case Report | DOI: 10.82333/kmck-0k81

Authors: Andreea Seder* 1

1Ophthalmology,UZ Brussel,Brussels,Belgium;Medicine,VUB,Brussels,Belgium

Purpose

To report and inform ophthalmologists on the risks of long term use of skin-lightening products, especially those containing high concentrations (>4%) of hydroquinone

Setting

A teritiary center in Brussels.

Report of case

A 67-year-old woman of African descent presented with a two-week history of headache and pain in the left eye. The patient presented with sudden vision loss in the left eye accompanied by excessive tearing.
On examination, the uncorrected visual acuity was hand movements in the left eye and 6/60 in the right eye.
Biomicroscopy of the left eye revealed conjunctival injection, nasal limbal corneal thinning, and a corneal perforation sealed by a large iris prolapse plug temporally. The AC was shallow but formed, and fibrin was present.

This patient presented with bilateral severe corneal melting and perforation which we associated with hydroquinone. In the case of this patient, all evaluations of systemic and local causes were negative and the appearance of the ulcers were not typical for Moorens, leading us to seek an alternative diagnosis. The dermatological review during the hospitalization led to the diagnosis of ochronosis. The patient reported daily use of skin-lightening creams containing hydroquinone of unknown concentration for a period of at least two years.

The patient underwent tectonic corneal transplantation in the left eye followed by a second procedure. During this procedure, an amniotic membrane was placed over the tectonic patch, followed by a scleral patch, a second layer of amniotic membrane with a conjunctival layer sutured on top, the application of an additional amniotic membrane, and the application of a megasoft contact lens.

 

Conclusion/Take home message

Considering the increasing number of reports linking hydroquinone-containing skin-lightening products to corneal and scleral melt, it is important that ophthalmologists are aware of the ocular side effects associated with hydroquinone-containing cosmetic products, and the dermatological signs pointing towards hydroquinone use. Early recognition and management of these complications could help prevent long-term ocular damage. Collaboration between dermatologists and ophthalmologists is essential in managing such patients to provide comprehensive care.